IL10 and inflammatory bowel disease: VNS has a potential anti-inflammatory effect on IBD by activating intestinal CAP, where ACh released from the ENS inhibits pro-inflammatory cytokine production and increases IL-10 production by interacting with immune cells (Bonaz et al. 2021, Zheng et al. 2024).